Use of tobacco and the co-prescription of sedative hypnotics have been shown to be risk factors for the misuse of prescribed opioids, but the association between these drugs has not yet been clarified.
...
The US Department of Health and Human Services has released a new set of recommendations for the coprescription of naloxone in patients at high-risk for opioid overdose.
In a new study, researchers investigated whether weekly and monthly subcutaneous buprenorphine depot formulations were noninferior to a daily sublingual combination of buprenorphine and naloxone for the...
The FDA’s Psychopharmacologic Drugs Advisory Committee recently reviewed and voted on whether to recommend lofexidine, a non-opioid drug, for the management of opioid withdrawal.
In a recent study, researchers investigated whether cannabis use influenced the relationship between pain and negative mood symptoms, such as depression, and whether self-efficacy influenced these...
Opioid and substance use disorders have reached epidemic levels in the United States. In a recent study, researchers explored the prevalence of visits due to opioid-related complications in US emergency...
In a recent study, researchers compared extended-release naltrexone hydrochloride with daily buprenorphine hydrochloride with naloxone hydrochloride for promoting abstinence from heroin or opioids among...
Primary care is often underutilized in the treatment of opioid and alcohol use disorders. In a recent study, researchers sought to determine whether collaborative care could help to improve outcomes among...
In a recent study, researchers analyzed rates of opioid-related overdose admissions to the ICU and in-hospital deaths, and their effects on ICU resources.
